Mark E. Goldman
Impact in
Papers in
-
- Receptor Mechanisms and Signaling 11
- Fibroblast Growth Factor Research 6
-
- Neuroscience and Neuropharmacology Research 7
- Co-authors
- Donald Patrick McDonnell (6 shared papers)Elisabetta Vegeto (2 shared papers)Dale E. Mais (7 shared papers)Bert W. O'Malley (1 shared paper)JACOB M. JUN. HOFFMAN (8 shared papers)Joanna Pike (1 shared paper)Thomas W. Hermann (1 shared paper)Emilio A. Emini (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (12 papers)Endocrinology (8 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Life Sciences (3 papers)Peptides (3 papers)
- Partner nations
- United StatesBelgiumIsrael
In The Last Decade
Mark E. Goldman
102 papers receiving 6.0k citations
Mark E. Goldman's Hit Papers
Peers
Comparison fields: 5 of 130
- Virology 775
- Genetics 1.8k
- Reproductive Medicine 482
- Infectious Diseases 903
- Toxicology 151
Countries citing papers authored by Mark E. Goldman
This map shows the geographic impact of Mark E. Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Goldman more than expected).
Fields of papers citing papers by Mark E. Goldman
This network shows the impact of papers produced by Mark E. Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Goldman. The network helps show where Mark E. Goldman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Goldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Hit paper breakdown → | 1993 | 681 |
| 2 | 1995 | 451 | |
| 3 | 1991 | 340 | |
| 4 | 1994 | 339 | |
| 5 | 1987 | 320 | |
| 6 | 1994 | 310 | |
| 7 | 1991 | 268 | |
| 8 | 1993 | 245 | |
| 9 | 1994 | 211 | |
| 10 | 1994 | 190 | |
| 11 | 1997 | 157 | |
| 12 | 1996 | 148 | |
| 13 | 1994 | 138 | |
| 14 | 2010 | 132 | |
| 15 | 1991 | 103 | |
| 16 | 1990 | 92 | |
| 17 | 1991 | 90 | |
| 18 | The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy. | 1988 | 81 |
| 19 | 2000 | 77 | |
| 20 | 1994 | 74 |
About Mark E. Goldman
Mark E. Goldman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Oncology, Infectious Diseases and Virology, having authored 105 papers that have together received 6.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), Estrogen and related hormone effects (15 papers), Receptor Mechanisms and Signaling (11 papers), Bone health and treatments (10 papers), HIV Research and Treatment (9 papers), Neuroscience and Neuropharmacology Research (7 papers), Analytical Chemistry and Chromatography (6 papers) and Fibroblast Growth Factor Research (6 papers). The work is most often cited by research in Virology (775 citations), Genetics (1.8k citations), Reproductive Medicine (482 citations), Infectious Diseases (903 citations) and Toxicology (151 citations). Mark E. Goldman has collaborated with scholars based in United States, Belgium and Israel. Frequent co-authors include Donald Patrick McDonnell, Elisabetta Vegeto, Dale E. Mais, Bert W. O'Malley, JACOB M. JUN. HOFFMAN, Joanna Pike, Thomas W. Hermann, Emilio A. Emini, William A. Schleif and Jayden A. O'Brien. Their work appears in journals such as Journal of Medicinal Chemistry, Endocrinology, Bioorganic & Medicinal Chemistry Letters, Life Sciences and Peptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.